Following a successful exhibition at MD&M West 2026, MB Medical Braider has concluded three days of technical engagements with global medical device OEMs and R&D engineers at the Anaheim Convention Center. Our showcase this year focused squarely on mitigating manufacturing risks and increasing yield rates for low-profile, micro-invasive devices.在2026年MD&M West展会成功亮相后，MB Medical Braider已在阿纳海姆会议中心与全球医疗器械原始设备制造商及研发工程师进行了为期三天的技术交流。今年，我们的展示重点聚焦于降低制造风险，并提升低轮廓、微创器械的良品率。

Medical Braiding Technology医用编织技术

The MB Medical Braider platform demonstrated precise tension management and RPM stability optimized for ultra-fine Nitinol micro-wires and stainless steel wires. These capabilities are specifically engineered for the demanding tolerances required in neurovascular stents and structural heart catheters — devices where sub-millimeter consistency is non-negotiable.MB医用编织机平台展现了针对超细镍钛合金微丝和不锈钢丝优化的精准张力控制与转速稳定性。这些功能专为神经血管支架和结构性心脏导管等高要求医疗器械所打造——在这些器械中，亚毫米级的一致性是不可妥协的。

Attendees were able to review live process data, wire tension curves, and pitch-per-inch (PPI) control logs directly at our booth.参会者可在我们的展位上直接查看实时过程数据、钢丝张力曲线以及每英寸螺距（PPI）控制日志。

Edge AI Visual Inspection边缘人工智能视觉检测

We also presented our latest continuous quality control system — Braid Guard — integrated directly with MB Medical Braider machinery. Developed by sister company Lynxi, Braid Guard uses real-time edge computing to detect micro-level braiding defects at standard production speeds.我们还推出了最新的连续质量控制系统——Braid Guard，该系统可直接与MB Medical编织机集成。Braid Guard由姊妹公司Lynxi研发，采用实时边缘计算技术，能够在标准生产速度下检测出微米级的编织缺陷。

The system ensures full traceability and aligns with zero-defect validation protocols required by Class II and Class III medical device manufacturers.该系统确保全程可追溯，并符合II类和III类医疗器械制造商所要求的零缺陷验证规程。

“The rigorous validation protocols and tight tolerances required by leading MedTech innovators drive our incremental updates. Exhibiting at MD&M West allows us to align our automated machinery and visual inspection systems directly with current regulatory and manufacturing standards.” — Engineering Team, MB Medical Braider

Exhibition Highlights展会亮点

We extend our sincere gratitude to the partners, quality managers, and engineers who visited Booth #3311. The conversations held at MD&M West 2026 directly inform the roadmap for our next product updates, and we look forward to continued collaboration.<b我们向莅临3311号展位的合作伙伴、质量经理和工程师致以诚挚的谢意。在2026年MD&M西展期间进行的交流，将直接为我们的下一次产品更新路线图提供重要参考，我们期待着未来的持续合作。

In conclusion, our presence at MD&M West 2026 has reinforced our commitment to advancing medical technology. We are excited about the future and are dedicated to driving innovation that enhances patient outcomes and operational efficiencies for our partners.总之，我们参加2026年MD&M西展进一步坚定了我们推动医疗技术发展的承诺。我们对未来发展充满期待，并致力于推动创新，以提升患者治疗效果，助力合作伙伴实现运营效率的优化。

As we look ahead, our focus remains on empowering medical device manufacturers through innovative solutions that not only meet but exceed regulatory requirements. The MB Medical Braider platform is designed with scalability in mind, ensuring that as our clients grow, we can support their needs with advanced technology and unparalleled service.

We deeply value the partnerships we build with clients and stakeholders. Their insights not only guide our product development but also foster a community of shared knowledge and best practices that elevate the entire industry.

Furthermore, collaboration with academic institutions and research organisations fuels our innovation pipeline. By engaging in joint research initiatives, we can leverage cutting-edge developments and translate them into practical applications for our clientele.

As the medical landscape continues to evolve, so too does our approach to innovation. We are committed to exploring new materials, technologies, and processes that will enhance the performance and reliability of our products. This forward-thinking mindset is crucial in maintaining our competitive edge in the industry.

The integration of AI technologies in our systems represents a significant leap forward in efficiency and accuracy. By employing real-time data analytics, we are able to optimise production processes dynamically, ensuring that quality is never compromised.

Attendees of the event expressed particular interest in our ability to provide bespoke solutions tailored to the unique challenges faced by medical device manufacturers. This adaptability positions MB Medical Braider as a pivotal partner in achieving operational excellence.

At MD&M West 2026, we demonstrated not only our cutting-edge equipment but also the expertise of our team. Engaging with industry leaders and participants has provided invaluable feedback that drives our future developments. Our aim is to further enhance the capabilities of the MB Medical Braider and ensure it remains at the forefront of medical technology.在2026年MD&M西展上，我们不仅展示了尖端设备，还彰显了团队的专业实力。与行业领袖和参会者们的交流互动，为我们带来了宝贵反馈，助力我们未来的研发创新。我们的目标是进一步提升MB医用编织机的性能，确保其始终处于医疗技术领域的最前沿。

The importance of quality control in medical device manufacturing cannot be overstated. With increasing scrutiny from regulatory agencies, the implementation of stringent quality assurance processes is essential. Braid Guard, our latest innovation, exemplifies this commitment, ensuring that every product meets the highest standards.

As a leading player in the medical device manufacturing sector, MB Medical Braider continues to innovate and adapt to the evolving demands of the industry. Our commitment to excellence is reflected in the advanced technology we deploy, focusing on the specific needs of our clients and the standards set by regulatory bodies.作为医疗设备制造领域的领军企业，MB医用编织机持续创新，积极适应行业不断变化的需求。我们对卓越的承诺体现在所采用的先进技术上，这些技术聚焦于客户的特定需求以及监管机构设定的标准。